tirzepatide scarborough me NICE's announcement on (Mounjaro) Tirzepatide Unlocked: A Practical Guide

*NOTE : These statements have not been evaluated by the Food and Drug Administration

From professional guidance, there will still be medications such as GLP-1 receptor agonists when appropriate

(Wegovy is recommended for weight loss, but not for short-term cosmetic reasons.) While this has received significant attention in the media, Ozempic and related GLP-1 medications are not designed to be used [for short-term, cosmetic weight loss], can lead to potential adverse events, and ultimately the weight that is lost will be regained, Christopher McGowan, MD, a gastroenterologist specializing in obesity medicine and endo bariatrics, told Forbes

(Primary completion November 2025, 68-week treatment period, 4mg/9mg/12mg dose arms

Digestive and hydration concerns Nausea, vomiting, constipation, diarrhea, reflux, and reduced appetite are common themes with many incretin-based and appetite-modifying medicines